Silexion Therapeutics SLXN
NASDAQ SLXN
$0.19 +0.02 (+15.01%)
As of: Oct 23, 2026 · 3:59 PM EDT

Silexion Therapeutics (SLXN) Price to Sales (2025)

Updated

Analysis

Silexion Therapeutics (SLXN) Price to Sales (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Silexion Therapeutics 132,452.92 -19.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 276.22
API Access

Silexion Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=SLXN&period=max&api_key=YOUR_API_KEY